by John Conrad | Jun 14, 2024 | NewsBrief
Congratulations to iBIO member Tempus AI and its founder, Eric Lefkofsky, on their remarkable achievement! We are thrilled to announce that Tempus AI, a trailblazing precision-medicine startup, is set to make its highly anticipated debut on the stock market this...
by John Conrad | Jun 14, 2024 | iBIO News
NewsBrief Weekly News Quiz: June 14 The Biotech Beat: Quiz Yourself on the Latest News Attention all life sciences enthusiasts! This quiz is your chance to demonstrate your mastery of the most recent developments in the dynamic world of biotechnology. Prepare to put...
by John Conrad | Jun 14, 2024 | iBIO News
From John: The news coverage of the BioPharma industry has been a study in contrasts. As I compile the daily NewsBrief, I come across numerous articles highlighting companies, both large and small, that are compelled to reduce their workforce due to insufficient...
by John Conrad | Jun 13, 2024 | NewsBrief
Inflammatory Bowel Disease (IBD) affects millions of people worldwide, causing chronic inflammation in the digestive tract and leading to debilitating symptoms. Current therapies often fail to provide adequate relief for many patients, highlighting the urgent need for...
by John Conrad | Jun 13, 2024 | NewsBrief
Meitheal Pharmaceuticals, a Chicago-based pharmaceutical company, has been named the second fastest growing company on Crain’s Fast 50 list. The company recorded an impressive 13,294.6% growth rate, with over $230 million in revenue and a total of 90 employees,...
